Pennsylvania EMS Department To Participate in Heart Attack Study - News - @ JEMS.com


Pennsylvania EMS Department To Participate in Heart Attack Study

Study participants will receive either a standard IV solution or glucose-insulin-potassium solution for 12 hours.


 
 

Lebanon Daily News | | Monday, August 9, 2010


Life Lion Emergency Medical Service and Penn State Milton S. Hershey Medical Center announced that they have received approval to begin participation in a heart-attack study called the IMMEDIATE Trial.

This National Institutes of Health-sponsored research study will test if an intravenous solution of glucose, insulin and potassium can reduce the likelihood of death from a heart attack, according to a news release from the Derry Township hospital. The study director is Dr. James Leaming.

Patient enrollment will start this month and will continue for up to one year. Patients with symptoms of a heart attack who are at least 30 years old and have positive findings on an EKG done by an EMS paramedic may be enrolled in the trial.

People with signs of heart failure and those receiving dialysis will not be enrolled. Due to the emergency nature of a heart attack, patients will not be able to give informed consent prior to starting the study drug. In the ambulance, the paramedics will notify patients of the study and they can decide to accept or decline participation. More detailed information will be provided at the hospital, and at that time patients can provide informed consent to continue or withdraw.

Study participants will receive either a standard IV solution or glucose-insulin-potassium solution for 12 hours. Which solution received is determined by chance. Neither the patient nor the medical staff will know which one has been assigned. All patients continue to receive standard care normally given.

Previous studies have shown that giving glucose-insulin-potassium as early as possible may protect the heart from damage until further therapies are available. However, there is no guarantee of benefit for trial participants.

Possible side effects include redness or inflammation at the IV site; change in blood sugar levels that may cause weakness, dizziness or thirstiness; change in potassium levels that may result in a rapid heartbeat or dizziness. Patients are monitored for side effects and treated if needed.

Use of the exception from informed consent provision in a study protocol is granted by the Institutional Review Board responsible for the initial and continuing review and approval of the research study. Patients may withdraw from the study at any time, with no disruption in care.



Related Links:


Copyright © 2013 LexisNexis, a division of Reed Elsevier Inc. All rights reserved. Terms and Conditions | Privacy Policy


Connect: Have a thought or feedback about this? Add your comment now
Related Topics: News, research, heart attack

What's Your Take? Comment Now ...

Buyer's Guide Featured Companies

Featured Careers & Jobs in EMS

Get JEMS in Your Inbox

 

Fire EMS Blogs


Blogger Browser

Today's Featured Posts

 

EMS Airway Clinic

Improving Survival from Cardiac Arrest Using ACD-CPR + ITD

Using active compression-decompression CPR with an ITD has been shown to improve 1-year survival from cardiac arrest by 33%.
More >

Multimedia Thumb

Philadelphia Fire Department Apologizes for Medic’s Jab at Police

Union head calls photos a slap in the face of officers.
Watch It >


Multimedia Thumb

D.C. Fire and EMS Crews Blame New Technology for Patient’s Death

Delayed response blamed on recurring dispatch problems.
Watch It >


Multimedia Thumb

Suspect Steals, Crashes Maryland Ambulance

One killed, others injured in Prince George’s County crash.
Watch It >


Multimedia Thumb

Tennessee Trench Rescue

Worker pulled from Roane County worksite.
More >


Multimedia Thumb

Time’s Ebola Firefighters

Doctors, nurses and others saluted for fighting virus.
More >


Multimedia Thumb

Car Strikes Manhattan Pedestrians

Seven people hurt when car jumps curb.
More >


Multimedia Thumb

Braun Ambulances' EZ Door Forward

Helps to create a safer ambulance module.
Watch It >


Multimedia Thumb

LMA MAD Nasal™

Needle-free intranasal drug delivery.
Watch It >


Multimedia Thumb

The AmbuBus®, Bus Stretcher Conversion Kit - EMS Today 2013

AmbuBus®, Bus Stretcher all-hazards preparedness & response tool
Watch It >


Multimedia Thumb

VividTrac offered by Vivid Medical - EMS Today 2013

VividTrac, affordable high performance video intubation device.
Watch It >


More Product Videos >